Cui bono…
Tag: marijuana
Nevada Officials Approve Plan To Let People With Marijuana Convictions Become Police Officers
Nevada officials have officially adopted a proposal to amend hiring standards for police officers to allow job candidates who were previously disqualified for certain marijuana-related offenses to now be eligible for law enforcement positions.
After holding a public hearing on the reform in October, the state Commission on Peace Officer Standards and Training (POST) voted to approve the change, revising regulations around hiring that currently prevent a person from becoming a peace officer if they have been convicted of an offense involving the unlawful use, sale or possession of a controlled substance.
The new language says the restriction doesn’t apply “to a person who has been convicted of an offense involving the unlawful use, sale, or possession of marijuana if the offense is not unlawful at the time the person submits an application for certification as a police officer.”
The commission said the change will expand the pool of eligible candidates for law enforcement positions and “aid agencies in the ability to fill much needed positions.” There will be no adverse effects from the reform, it says, nor additional costs to regulators.
Approval of the change, which was first proposed in May, does not mean that officers can use cannabis once employed, but it represents a significant policy change, especially given that the current rules are written in a way that explicitly emphasizes the no-tolerance policy for marijuana.
Study Finds ‘No Evidence’ That Medical Marijuana Causes Cognitive Impairment In Patients With Chronic Health Problems
Findings of a study examining marijuana’s neurocognitive effects “suggest that prescribed medical cannabis may have minimal acute impact on cognitive function among patients with chronic health conditions”—which may come as a relief to long-term cannabis patients who are concerned about potential neurological drawbacks of the drug.
Authors of the report, published last month in the peer-reviewed journal CNS Drugs, wrote that they found “no evidence for impaired cognitive function when comparing baseline with post-treatment scores.”
To conduct the study, researchers had 40 people in Australia self-administer a single dose of medical marijuana in a laboratory setting, following instructions on the product label. Participants were then tested on an array of neuropsychological metrics—including multitasking, pattern recognition memory, reaction time, rapid visual information processing and spatial working memory, among others—and surveyed on their subjective experience.
“The absence of evidence for cognitive impairment following medical cannabis self-administration was surprising,” the study says, “given prior and substantive evidence that non-medical (‘recreational’) cannabis use reliably impairs a range of cognitive functions. At the same time, these findings are consistent with two systematic reviews published in the last year that suggest that medical cannabis, when used regularly and consistently for a chronic health concern, may have little if any impact on cognitive function.”
Germany Delays Final Vote On Marijuana Legalization Bill Until Next Year
A final vote on a bill to legalize marijuana in Germany that was initially planned for this week has been called off amid concerns from leaders of the country’s Social Democratic Party (SPD). The delay means that action on the landmark proposal will be postponed until next year.
“It always has to be approved by the parliamentary groups in the end,” Dirk Heidenblut, an SPD member of Germany’s Bundestag who is responsible for the party’s cannabis policy, said in an Instagram post. “And if a faction leader, in this case the SPD, has concerns, then it cannot be set up yet.”
Despite the delay, Heidenblut added that as long as the measure advances by the end of January, the delay shouldn’t meaningfully impact the schedule for implementing legalization.
If lawmakers pass the bill, the early stages of reform—including home cultivation for personal use—would begin as soon as April.
Toxicology Identifies Cannabis in the Bones of Medieval Italians
Archaeologists excavating in a 17th-century hospital crypt in Milan, Italy, recovered the skeletons of nine people. Using tools of toxicology, they have now identified “the first archaeological evidence” of THC, the psychoactive component of cannabis, in human bones from the Modern Age.
The cannabinoids from cannabis, such as tetrahydrocannabinol [THC], one of the psychoactive properties associated with the plant, are stored in various tissues in the body, including hair and bones. A 2013 a study published in the journal “Drug and Alcohol Dependence,” found that THC can be detected in human bones “several weeks” after the last cannabis use. However, the associated detection technologies have changed – a lot – over the last decade.
The exact mechanisms of how cannabinoids are stored in bones, and how long they remain detectable, varies from person to person, and greatly depends on frequency of use, dosage, and individual metabolism. Bones, essentially act like a reservoir for cannabinoids, and their detection can be used in forensic and clinical settings to assess past cannabis use. But now, a team of researchers have identified THC in the 17th century bones of people buried under a hospital in Milan, Italy.
In a new study, Dr. Gaia Giordano at the University of Milan said that she her colleagues excavated and tested the skeletons of nine people from a 17th century crypt at Milan’s Ca’ Granda hospital. The bone samples were powdered, separated and purified, before being liquified and subjected to mass spectrometry, to identify the chemical components.
The results were subsequently analyzed using the tools of toxicology, the study of chemical substances in living organisms including humans. Toxicologists analyze how substances are absorbed, distributed, metabolized, excreted, and their toxic effects. Whether eaten or inhaled, cannabinoids are trapped and preserved after being absorbed into the bloodstream, and they are ultimately stored in bone tissue.
The team identified THC and cannabidiol (CBD) molecules within the thigh bones of a young man and middle-aged woman, who were both buried between 1638 AD and 1697 AD.
Hundreds of Illegal Chinese-owned Marijuana Operations Taking Over Maine
Hundreds of illegal Chinese-owned marijuana growing operations have been popping up across Maine over the past three years.
On Tuesday, Nov. 28, local law enforcement shut down an illegal marijuana grow that was being operated in a building located behind a licensed marijuana cultivation facility in Franklin County.
Officers from the Wilton Police Department were assisting investigators from the Maine Office of Cannabis Policy (OCP) during a routine follow-up inspection of a licensed facility in Wilton when they raided the illegal operation, authorities said in a press release posted on social media.
“It’s a place that has been on the radar,” State Rep. Mike Sobeleski (R) told The Epoch Times, adding that he had visited the facility previously. The Republican lawmaker said he had learned about the raid just minutes before Tuesday’s interview with The Epoch Times to discuss the illegal marijuana operations being run by Chinese nationals throughout the state.
Earlier this month, a man identifying himself as the property manager told the Maine Wire that the building was being used to grow marijuana and that operators paid about $30,000 per month in rent.
He also reportedly told the news outlet that the facility was being run by four Asian men who claimed they were from New York, California, Washington, and Massachusetts.
Top Federal Agency Promotes New Marijuana Research Center Amid Scientists’ Complaints About ‘Complex’ Study ‘Barriers’ Under Prohibition
A top federal health agency says it recognizes that there are ample concerns among scientists about how they’ve “encountered barriers that have hampered their research” into marijuana under federal prohibition, including “complex” federal regulations and inadequate supplies of cannabis.
That’s why the National Institutes of Health (NIH) is now seeking to resolve some of those challenges by standing up a Resource Center for Cannabis and Cannabinoid Research, an official said in a blog post on Tuesday.
NIH posted a notice of funding opportunity late last month, explaining how it’s seeking an entity to operate the center through a cooperative agreement in order to “address challenges and barriers to conducting research on cannabis and its constituents.”
To help facilitate that process, the National Center for Complementary and Integrative Health’s (NCCIH) Patrick Still announced that the health agency will be holding a webinar on January 25 to provide potential applicants with technical assistance.
“There’s growing interest in potential therapeutic uses of cannabis and its constituents among both health care providers and the public,” Still, who is a program director for NCCIH’s Basic and Mechanistic Research branch, wrote. “Substances in cannabis have a variety of pharmacologic effects, and rigorous research is needed to understand their mechanisms of action and investigate their possible value in helping to manage health conditions.”
“However, investigators working in this field have encountered barriers that have hampered their research,” he said, pointing to feedback NCCIH received as part of a request for information last year.
“The barriers that many of them have mentioned include difficulty meeting complex federal and state regulatory requirements, problems obtaining cannabis products suitable for research, a lack of validated measures of cannabis use and exposure, and inadequate scientific infrastructure to support research studies,” Still wrote.
It’s Time To Rethink Termination Of Employees For Positive Marijuana Drug Tests
As a social conservative, alcohol has always been my drug of choice. For me, the odor of marijuana on a city street evokes a discomfiting sense of lawlessness and societal decline. But I remind myself that Carrie Nation, who attacked alcohol-service establishments with a hatchet in the lead-up to prohibition, had the same feelings toward the bourbon I so relish. And so it’s time to bury my own hatchet when it comes to cannabis.
Irrespective of one’s thoughts on marijuana legalization, we have reached a point of no return both in terms of culture and economics. More than 50 percent of Americans live in jurisdictions where recreational marijuana is legal, and 74 percent have access to medical cannabis. Revenue of the U.S. cannabis market will exceed $30 billion in 2023 and will increase at double-digit rates for the foreseeable future. State treasuries hunger for the tax revenue.
Given its legality, given its ubiquity, it is time we stop gratuitously destroying careers based on marijuana tests that say nothing about impairment. The problem is particularly acute in the transportation industry, where employers are compelled by federal law to randomly test employees and remove them from their safety sensitive positions based on positive tests. Frequently, that removal is followed by termination by the employer and license action by the regulating agency.
Driven by my sympathy for the affected individuals, I have handled numerous cases for employees who have lost their jobs due to positive tests. Moreover, most of the cases I have handled have resulted in reinstatement—sometimes due to specimen collection errors, occasionally due to deficient medical review and once due to a laboratory’s failure to properly validate its testing methodology. However, our nation’s marijuana dilemma calls for a broader approach: a change in policy.
It is undisputed that the mandated testing methodologies do not reflect time-specific impairment; however, that limitation has always been met with a collective shrug by regulators. After all, the “prohibited drugs” for which the federal government requires testing are all illegal; therefore, it is considered sufficient that the test confirms that, at some time in the recent past, the employee used the drug.
By contrast, a “positive” test for the legal drug of alcohol has always required proof of current intoxication.
The obvious solution would be to apply the alcohol current intoxication approach to cannabis. The problem is that, currently, there is no reliable test for current marijuana impairment. In response to this dilemma, we have seen a sub rosa movement by certain decision makers and regulators cutting some slack for employees who test positive for marijuana.
People With Anxiety Report Better Sleep On Days They Use Marijuana Compared To Alcohol Or Nothing At All, Study Finds
People with anxiety experience better quality sleep on days when they use marijuana compared to days when they use alcohol or nothing at all, a new federally funded study has found.
For the study, published in the journal Drug and Alcohol Review, researchers at the University of Colorado, Colorado State University and University of Haifa analyzed the subjective sleep quality of 347 people who reported using cannabis to treat anxiety. They wanted to understand the different ways sleep was affected by the use of marijuana, alcohol, neither or both on a given day.
To that end, people participating in the study were asked to fill out daily surveys for 30 days, recounting their substance use and subjective sleep experience the night prior. Researchers compared outcomes from non-use days, cannabis-only days, alcohol-only days and co-use days.
“Compared to non-use, participants reported better sleep after cannabis-use-only and after co-use, but not after alcohol-use-only,” the authors, who received funding for the study from a National Institutes of Health grant, wrote.
Wisconsin Governor Grants Dozens Of Marijuana Pardons As Advocates Pressure GOP Leaders To Advance Legalization
The governor of Wisconsin has granted another round of pardons, including dozens issued for people with prior marijuana convictions.
As Democratic lawmakers in the state continue to push for legalization amid opposition by GOP legislative leaders, Gov. Tony Evers (D) announced on Tuesday that he’s exercised his constitutional authority to provide relief to 82 more people, raising the total number of pardons under his administration to 1,111.
About one-third of the latest pardons were granted to people who had marijuana possession, cultivation or sales convictions on their records, with the majority of the cannabis cases related to simple possession. Another third of the overall grants of clemency went to people with other drug convictions.
Hellbound and Down 
You must be logged in to post a comment.